FLUDARABINE-BASED COMBINATION CHEMOTHERAPY IN RELAPSED MANTLE CELL LYMPHOMA - THE EXPERIENCE OF A SINGLE CENTER

被引：0
|
作者：
Moita, F. [1 ]
Santos, J. [1 ]
da Silva, M. G. [1 ]
机构：
[1] Inst Portugues Oncol Francisco Gentil, Lisbon, Portugal
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0256
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [31] Retrospective analysis of 115 unselected patients with mantle cell lymphoma: Single center experience.
    Seval, Guldane Cengiz
    Bulat, Bugu
    Ozel, Fulya
    Tasci, Onur
    Kuzu, Isinsu
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Topcuoglu, Pervin
    Ozcan, Muhit
    Gurman, Gunhan
    Demirer, Taner
    Ilhan, Osman
    Akan, Hamdi
    Beksac, Meral
    Arslan, Onder
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Excellent Outcome of Related Donor Hematopoietic Stem Cell Transplantation in Children with Fanconi Anemia Using Fludarabine-Based Conditioning Regimen: A Single Center Experience in TURKEY
    Ileri, T.
    Ertem, M.
    Ince, E. Unal
    Asarcikli, F.
    Cakmakli, H.
    Uysal, Z.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S443 - S443
  • [33] Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis
    Dong-Yeop Shin
    Seok Jin Kim
    Dok Hyun Yoon
    Yong Park
    Jee Hyun Kong
    Jeong-A Kim
    Byung-Su Kim
    Hyo Jung Kim
    Jong-Ho Won
    Sung-Kyu Park
    Won Seog Kim
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 865 - 873
  • [34] Chemotherapy for mantle cell lymphoma
    Sinharay, R.
    GUT, 2007, 56 (10) : 1479 - 1479
  • [35] Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: an interim analysis
    Shin, Dong-Yeop
    Kim, Seok Jin
    Yoon, Dok Hyun
    Park, Yong
    Kong, Jee Hyun
    Kim, Jeong-A
    Kim, Byung-Su
    Kim, Hyo Jung
    Won, Jong-Ho
    Park, Sung-Kyu
    Kim, Won Seog
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (04) : 865 - 873
  • [36] BRENTUXIMAB VEDOTIN FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: SINGLE CENTER EXPERIENCE
    Valiev, Timur
    Tsaplina, Nataly
    Kirgizov, Kirill
    PEDIATRIC BLOOD & CANCER, 2022, 69 : S589 - S589
  • [37] Relapsed, Refractory, or Advanced Hodgkin Lymphoma: A Single-Center Experience
    Boileve, Alice
    Grignano, Eric
    Bouscary, Didier
    Fourquet, Alain
    Deau-Fischer, Benedicte
    Kirova, Youlia
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : E27 - E31
  • [38] Successful Outcome With Fludarabine-Based Conditioning Regimen for Hematopoietic Stem Cell Transplantation From Related Donor in Fanconi Anemia: A Single Center Experience From Turkey
    Kuskonmaz, Baris
    Unal, Sule
    Bayhan, Turan
    Eyuboglu, Selin Aytac
    Tavil, Betul
    Cetin, Mualla
    Gumruk, Fatma
    Cetinkaya, Duygu Uckan
    PEDIATRIC BLOOD & CANCER, 2016, 63 (04) : 695 - 700
  • [39] Improved outcome in HSCT for osteopetrosis following a busulfan and fludarabine-based conditioning: a single centre experience
    Moshous, D.
    Touzot, F.
    Frange, P.
    Heritier, S.
    Cormier-Daire, V.
    Baujat, G.
    Pangrazio, A.
    Villa, A.
    Blanche, S.
    Fischer, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S152 - S153
  • [40] Ibrutinib for relapsed/refractory mantle cell lymphoma: 7-year experience
    Grilo, I. T.
    Couto, M. E.
    Freitas, J. F.
    Pereira, D. P.
    Moreira, C.
    Chacim, S.
    Domingues, N.
    Santo, A. E.
    Martins, A.
    Viterbo, L.
    Oliveira, I.
    Moreira, I.
    Mariz, J. M.
    ANNALS OF ONCOLOGY, 2019, 30
12345